![Jennie Wilborgsson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jennie Wilborgsson is currently Chief Operating Officer at Ascelia Pharma AB, starting in 2025.
Formerly, Ms. Wilborgsson was Head of the Global Clinical Project Management Department at KLIFO A. Education includes an undergraduate degree from the University of Lund.
| Società | Posizione | Inizio |
|---|---|---|
| ASCELIA PHARMA AB | Direttore operativo | 01/11/2025 |
| Società | Posizione | Fine |
|---|---|---|
KLIFO A/S
 KLIFO A/S Miscellaneous Commercial ServicesCommercial Services Provides clinical research services | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
| Aziende private | 3 |
|---|---|
KLIFO A/S
KLIFO A/S Miscellaneous Commercial ServicesCommercial Services Provides clinical research services | Commercial Services |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ascelia Pharma AB
 Ascelia Pharma AB Pharmaceuticals: MajorHealth Technology Operates as oncology-dedicated drug development company, which develops novel drugs to improve life expectancy | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
